COCOKIND POSTBIOTIC ACNE SERUM- salicylic acid 1.5% liquid

Cocokind postbiotic acne serum by

Drug Labeling and Warnings

Cocokind postbiotic acne serum by is a Otc medication manufactured, distributed, or labeled by Onekind.25. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient

Salicylic acid 1.5%.

Purpose

Acne treatment

Use

For the treatment of acne.

Warnings

For external use only.​

When using this product

When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION

Gently massage or pat 2-3 drops of serum onto clean skin, avoiding eye area

Use am and pm.

Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor.

If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Inactive ingredients

Aloe barbadensis leaf juice, propanediol, glycerin, sodium citrate, musa sapientum (banana) fruit extract, gluconolactone, lysolecithin, sclerotium gum, maltodextrin, sodium benzoate, sodium hydroxide, pullulan, xanthan gum, lactobacillus ferment, tocopherol, silica, helianthus annuus (sunflower) seed oil, calcium gluconate, beta-glucan, 1,2-hexanediol, caprylyl glycol, pyrus malus (apple) fruit extract, morinda citrifolia fruit extract.

Cocokind postbiotic acne serum

INGREDIENTS AND APPEARANCE

COCOKIND POSTBIOTIC ACNE SERUM 
salicylic acid 1.5% liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 79356-210
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	1.5 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
PULLULAN (UNII: 8ZQ0AYU1TT)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
SUNFLOWER OIL (UNII: 3W1JG795YI)
CALCIUM GLUCONATE (UNII: SQE6VB453K)
APPLE (UNII: B423VGH5S9)
MORINDA CITRIFOLIA FRUIT (UNII: 7829X3G2X5)
BETASIZOFIRAN (UNII: 2X51AD1X3T)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
1,2-HEXANEDIOL (UNII: TR046Y3K1G)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
SODIUM BENZOATE (UNII: OJ245FE5EU)
SODIUM CARBOXYMETHYL .BETA.-GLUCAN (DS 0.65-0.85) (UNII: 2YGO1190AP)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
ALOE VERA LEAF (UNII: ZY81Z83H0X)
PROPANEDIOL (UNII: 5965N8W85T)
BANANA (UNII: 4AJZ4765R9)
LACTOBACILLUS FERMENTUM (UNII: 2C1F12C6AP)
GLUCONOLACTONE (UNII: WQ29KQ9POT)
XANTHAN GUM (UNII: TTV12P4NEE)
LYSOPHOSPHATIDYLCHOLINE, SOYBEAN (UNII: CQD833204Z)
TOCOPHEROL (UNII: R0ZB2556P8)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM CITRATE (UNII: 1Q73Q2JULR)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 79356-210-10	1 in 1 CARTON	01/10/2022
1		30 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	01/10/2022

Labeler - Onekind.25 (080286020)